Acumen Pharmaceuticals, Inc. - Common Stock (ABOS)
1.4900
+0.0100 (0.68%)
Acumen Pharmaceuticals Inc is a biotechnology company focused on developing innovative therapeutics aimed at treating neurodegenerative diseases, particularly Alzheimer's disease
The company's research emphasizes the creation of targeted treatments that aim to modify disease progression and improve cognitive function in patients. Acumen leverages advanced scientific methodologies to explore novel mechanisms of action, striving to bring meaningful advancements to the field of neurology and enhance the quality of life for those affected by these challenging conditions.
Frequently Asked Questions
Is Acumen Pharmaceuticals, Inc. - Common Stock publicly traded?
Yes, Acumen Pharmaceuticals, Inc. - Common Stock is publicly traded.
What exchange does Acumen Pharmaceuticals, Inc. - Common Stock trade on?
Acumen Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Acumen Pharmaceuticals, Inc. - Common Stock?
The ticker symbol for Acumen Pharmaceuticals, Inc. - Common Stock is ABOS on the Nasdaq Stock Market
What is the current price of Acumen Pharmaceuticals, Inc. - Common Stock?
The current price of Acumen Pharmaceuticals, Inc. - Common Stock is 1.490
When was Acumen Pharmaceuticals, Inc. - Common Stock last traded?
The last trade of Acumen Pharmaceuticals, Inc. - Common Stock was at 11:30 am EST on February 5th, 2025